Arcadia Biosciences Receives $855,500 Grant to Fund Next-Stage Development of Wheat with Reduced Celiac Disease Potential (Business Wire)

%if:content

DAVIS, Calif.----Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, today announced that it has received a two-year, $855,500 Small Business Technology Transfer grant funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the American Recovery and Reinvestment Act .

Read more:
Arcadia Biosciences Receives $855,500 Grant to Fund Next-Stage Development of Wheat with Reduced Celiac Disease Potential (Business Wire)